Higher BMI increases the risk of psoriasis and may aggravate the existing psoriasis. On the other hand higher BMI in psoriatic patients could be protective against development of osteoporosis but may increase the risk of liver and renal toxicity from methotrexate and cyclosporine. Then, what would be the management plan of a psoriatic patient with higher BMI?